SETBP1 and chronic neutrophilic leukemia: Recent research has showed that new biomarkers such as SETBP1 and/or ASXL1 mutations may be associated with poor prognosis in CNL and CMML [8], and presence of SETBP1 mutation in CNL suggested a pathogenic role associated with progression of blast phase transformation [8].